Loading viewer...
earnings
Format: PDF earnings
Amgen's Q2 2023 earnings presentation delivered on August 3, 2023, includes forward-looking statements on product performance, acquisitions including Horizon Therapeutics, and financial guidance. The deck covers clinical developments, commercial updates, and strategic initiatives across Amgen's biopharmaceutical portfolio. Risk factors and safe harbor disclosures detail regulatory, manufacturing, and competitive challenges affecting the company's operations.
Antero Resources Q3 2016 Earnings Presentation
earningsearnings
15 Pages
Antero Resources Corporation
earnings
17 Pages
Visa
Huntsman 4Q22 Earnings Summary – February 2023
earningsearnings
14 Pages
Huntsman Corporation